Key Developments: STAR Pharmaceutical Ltd (SRPT.SI)

SRPT.SI on Stock Exchange of Singapore

0.05SGD
10 Jul 2014
Price Change (% chg)

$0.00 (+3.77%)
Prev Close
$0.05
Open
$0.05
Day's High
$0.05
Day's Low
$0.05
Volume
128,000
Avg. Vol
59,328
52-wk High
$0.11
52-wk Low
$0.03

Search Stocks

Latest Key Developments (Source: Significant Developments)

STAR Pharmaceutical Ltd proposes disposal
Monday, 16 Jun 2014 07:17am EDT 

STAR Pharmaceutical Ltd:Proposes disposal of 80 pct equity interest in Beida Shijia Technology Development Co. Ltd; and 46 pct equity interest in Beijing Shijia Jiu Sheng Yuan Pharmaceutical Technology Co., Ltd.  Full Article

STAR Pharmaceutical does not declare dividend
Thursday, 15 May 2014 05:46am EDT 

STAR Pharmaceutical Ltd:Says no dividend has been declared/recommended for the period ended March 31.  Full Article

STAR Pharmaceutical Ltd announces disposal of equity interest in Jiu Sheng Yuan, Beida Shijia Technology Development, Beijing Shijia Jiu Sheng Yuan Pharmaceutical Technology
Wednesday, 12 Mar 2014 05:26am EDT 

STAR Pharmaceutical Ltd:Says its subsidiary Hainan Star Pharmaceutical Co., Ltd (PRC) has on March 11 entered into a sale and purchase agreement for the disposal of its 14 pct equity interest in Jiu Sheng Yuan to Zhou Yawei.Says consideration for the Jiu Sheng Yuan Disposal is 1 yuan in cash.Says Hainan Star has also entered into a sale and purchase agreement with Jin Merchants Alliance Holding Co., Ltd and Beida Shijia Technology Development Co., Ltd.For sale of 80 pct of the equity interest in Beida Shijia, being the entire equity interest in Beida Shijia held by Hainan Star and sale of 46 pct of the equity interest in Jiu Sheng Yuan, being the entire equity interest in Jiu Sheng Yuan held by Hainan Star after the Jiu Sheng Yuan disposal.Aggregate sale consideration for the proposed disposal is 40,000,001 yuan.Says it expects to receive net proceeds of 25,000,001 yuan from the proposed disposal after deducting the introducer’s fee of 15,000,000 yuan from the consideration of 40,000,001 yuan.Says net proceeds will be used to strengthen its working capital and fund the expansion of its product portfolio.  Full Article

STAR Pharmaceutical Ltd Does Not Declare Dividend
Wednesday, 13 Nov 2013 04:49am EST 

STAR Pharmaceutical Ltd announced that no dividend has been declared or recommended for the period ended September 30, 2013.  Full Article

STAR Pharmaceutical Ltd Does Not Declare Dividend
Monday, 13 May 2013 06:31am EDT 

STAR Pharmaceutical Ltd announced that no dividend has been declared for the period ended march 31, 2013.  Full Article

STAR Pharmaceutical Ltd Does Not Declare Dividend
Friday, 1 Mar 2013 05:56am EST 

STAR Pharmaceutical Ltd announced that no dividend has been declared for the year ended December 31, 2012.  Full Article

STAR Pharmaceutical Ltd Comments On Q4, FY 2012 Earnings Guidance
Friday, 18 Jan 2013 04:25am EST 

STAR Pharmaceutical Ltd announced that for fourth quarter 2012 and fiscal 2012, it expects to report a loss, financial results were adversely affected by a substantial write-off of an intangible asset of Category I Chinese Medicine Drug, Yanning Capsules, and allowance for impairment of deposit due to termination contract of R&D patent right acquisition.  Full Article

STAR Pharmaceutical Ltd Does Not Declare Dividend
Monday, 12 Nov 2012 05:03am EST 

STAR Pharmaceutical Ltd announced that no dividend has been declared for the period ended September 30, 2012.  Full Article

STAR Pharmaceutical Ltd Announces Appointment Of Chairman
Wednesday, 24 Oct 2012 05:32am EDT 

STAR Pharmaceutical Ltd announced that Mr. Xu Zhi Bin will be appointed as an Executive Director and Executive Chairman of the Company with effect from November 19, 2012 in place of Ms. Wong Kai who has resigned as Executive Director and Executive Chairman.  Full Article

STAR Pharmaceutical Ltd Announces Change of Chief Financial Officer
Monday, 15 Oct 2012 05:33am EDT 

STAR Pharmaceutical Ltd announced that Ms. Chung Yim Karie will appointed as Chief Financial Officer of the Company with effect from October 15, 2012 in place of Poon Chun Keung who has resigned as Chief Financial Officer. Mr. Poon Chun Keung the Chief Financial Officer of the Company has tendered his resignation on September 13, 2012.  Full Article

No consensus analysis data available.
Search Stocks